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Abstract
Extended-spectrum β-lactamase (ESBL)- and plasmid mediated AmpC-type cephalospori-
nase (pAmpC)-producing Escherichia coli (ESBL/pAmpC E. coli) in food-producing animals
is a major public health concern. This study aimed at quantifying ESBL/pAmpC-E. coli
occurrence and transfer in Italy’s broiler production pyramid. Three production chains of an
integrated broiler company were investigated. Cloacal swabs were taken from parent stock
chickens and offspring broiler flocks in four fattening farms per chain. Carcasses from sam-
pled broiler flocks were collected at slaughterhouse. Samples were processed on selective
media, and E. coli colonies were screened for ESBL/pAmpC production. ESBL/pAmpC
genes and E. coli phylogroups were determined by PCR and sequencing. Average pairwise
overlap of ESBL/pAmpC E. coli gene and phylogroup occurrences between subsequent
production stages was estimated using the proportional similarity index, modelling uncer-
tainty in a Monte Carlo simulation setting. In total, 820 samples were processed, from which
513 ESBL/pAmpC E. coli isolates were obtained. We found a high prevalence (92.5%, 95%
CI 72.1–98.3%) in day-old parent stock chicks, in which blaCMY-2 predominated; prevalence
then dropped to 20% (12.9–29.6%) at laying phase. In fattening broilers, prevalence was
69.2% (53.6–81.3%) at the start of production, 54.2% (38.9–68.6%) at slaughter time, and
61.3% (48.1–72.9%) in carcasses. Significantly decreasing and increasing trends for
respectively blaCMY-2 and blaCTX-M-1 gene occurrences were found across subsequent pro-
duction stages. ESBL/pAmpC E. coli genetic background appeared complex and bla-gene/
phylogroup associations indicated clonal and horizontal transmission. Modelling revealed
that the average transfer of ESBL/pAmpC E. coli genes between subsequent production
stages was 47.7% (42.3–53.4%). We concluded that ESBL/pAmpC E. coli in the broiler pro-
duction pyramid is prevalent, with substantial transfer between subsequent production
levels.
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Introduction
Extended spectrum cephalosporins (ESCs) are considered critically important antimicrobials
(CIAs) in both human and veterinary medicine [1,2]. Resistance to these antimicrobials is
therefore a major public health concern due to the risks of therapy failure [3]. Resistance in
Enterobacteriaceae, such as Escherichia coli, caused by production of extended-spectrum β-lac-
tamases (ESBLs) or AmpC β-lactamases (pAmpCs) and transferability of resistance mecha-
nisms are of particular importance, as the encoding genes (hereafter ESBL/pAmpC genes) are
often located in promiscuous plasmids [4]. This property of EBSL/pAmpC genes enables their
exchange between bacteria, including pathogens, and favours transmission between animals
and humans [5]. Usage of ESCs in poultry has been restricted since 2012 in the European
Union (EU) [6] except for occasional use in (grand)parent hatcheries [7,8]. However, numer-
ous studies have shown high prevalence rates of ESBL/AmpC-producing E. coli (ESBL/
pAmpC E. coli) in broiler flocks across Europe [9–11], even in countries with low antimicro-
bial use in livestock [7,12]. The presence of ESBL/pAmpC E. coli has been evidenced at all lev-
els of the broiler production pyramid from breeding farms [13], hatcheries [14], fattening
farms [15], slaughterhouses [16] to retail meat [17]. Whether broiler meat contaminated with
ESBL/pAmpC E. coli represents an important source of human infections is debatable [18].
For instance, a recent comparative risk assessment estimated the exposure to ESBL/pAmpC E.
coli through consumption of chicken meat to be lower than beef and pork [19], whereas a
meta-analysis identified poultry products as the most likely source of human ESC-resistant
infections [20]. The zoonotic transmission potential has prompted many investigations, not
only on the prevalence of ESBL/pAmpC E. coli, but also on their transmission routes along the
broiler production pyramid. A recent review [21] summarised the transfer of ESBL/pAmpC-
producing bacteria in four major pathways; vertical transmission from parent to offspring,
transmission in the hatchery, horizontal transmission in fattening farms, and horizontal trans-
mission between farms or from the environment. Additionally, the authors stressed the need
for more quantitative data on these transmission pathways.
In Italy, data on both prevalence and transmission dynamics of EBSL/pAmpC genes in
poultry are lacking. This study aimed to establish a baseline prevalence of ESBL/pAmpC E. coli
in the broiler production pyramid and to characterise the genetic background of resistant iso-
lates in order to assess their transfer between subsequent levels of the broiler production
pyramid.
Materials and methods
Sample collection
Three production chains (chain A, B, and C) of an integrated broiler production company in
Northern Italy (specifically in Veneto, Lombardy, and Friuli-Venezia Giulia regions) were
monitored from January 2017 to January 2018. In each of the 40 sampling visits, faecal samples
from 20 randomly selected healthy birds were taken by cloacal swabs in the farms, and 20 car-
casses were collected at the slaughterhouse. For each chain, sample collection started at the top
of the production pyramid by sampling day-old Parent Stock (PS) chicks, which were the
progeny of the Grandparent Stock (GPS) flock located elsewhere. Imported day-old PS chicks
were sampled upon arrival to the rearing farm within one hour from delivery. Due to time
constraints, samples were not collected for PS chicks of chain B. The same flock of PS chickens
was sampled again during the laying period (~30-weeks-old) at the production farm (PS
breeders), in which they were moved at the age of 21-weeks. Sampled breeder flocks were not
combined with other flocks at the production farms. The offspring of the sampled PS breeders
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were tracked and sampled in four commercial fattening farms per production chain at two
time points; at the age of one-day-old (broiler chicks), and around 30th day of age, within the
last week prior slaughter (broilers) (S1 Table). Samples in each broiler farm were collected
from the same poultry house, which contained only the progeny of the previously sampled PS
breeders. Finally, 20 carcasses from the previously sampled broilers were collected at the
slaughterhouse after the chilling process. All breeder flocks and all broiler flocks, except three
of them, received antibiotic treatment, mainly amoxicillin for therapeutic reasons unrelated to
this study (S1 Fig). Broilers from the three monitored chains were all processed in the same
slaughterhouse in Veneto region. Cloacal swabs from birds were collected by veterinarians of
the private company as part of the routine monitoring of the flock health status and conducted
in compliance with good veterinary practices.
Isolation and detection
Cloacal swabs were directly streaked on Eosin Methylene Blue agar (Microbiol, Italy) supple-
mented with 1mg/L cefotaxime (CTX-EMB) and incubated at 37±0.5 ˚C for 20±2h. Carcasses
were analysed by both a qualitative and quantitative method. For the qualitative method, car-
casses were rinsed with Buffer Peptone Water (BPW), rinsates were incubated (37±0.5 ˚C for
20±2h) and streaked on CTX-EMB. For the quantitative method, rinsates and three serial dilu-
tions (10−1 to 10−3) were plated on CTX-EMB for subsequent enumeration. One to two mor-
phologically typical E. coli colonies on CTX-EMB (metallic green sheen) were isolated from
each sample and subjected to species confirmation by combination of indole test and PCRs
targeting E. coli housekeeping genes [22]. Confirmed E. coli isolates were screened for ESBL/
pAmpC production by double-disk synergy test using cefotaxime (30 μg) and ceftazidime
(30 μg) discs with and without clavulanic acid (10 μg) and according to CLSI guidelines [23].
Additionally, a cefoxitin disc (30 μg) was used to detect potential AmpC-producers.
Molecular characterisation
ESBL/pAmpC gene groups [24] and E. coli phylogroups [25] were detected by multiplex PCRs
for all phenotypically resistant isolates. For a selection of 119 isolates, ESBL/AmpC genes were
sequenced (Macrogen, Spain) after amplification with the primers described by Dierikx et al.
[26] to identify gene variants. This selection was done considering the variability of ESBL/
pAmpC genes and E. coli groups per sampling (at least one isolate per phylogroup-bla gene
combination per sampling). Moreover, isolates with an AmpC phenotype, but negative for
pAmpC genes by multiplex PCR, were analysed for chromosomal mutations in the ampC pro-
moter/attenuator (cAmpC) according to Haldorsen et al. [27].
Data analysis
Prevalence of ESBL/pAmpC E. coli for each production stage was calculated based upon faecal
samples or carcasses being positive to ESBL/pAmpC E. coli (at least one isolate). Prevalence
estimates and corresponding 95% confidence intervals (95% CI) were adjusted for clustering
of observations at the chain and farm levels using cluster-robust standard errors. Chi-square
statistic for trends in proportions was used to test the significance of trends in the relative fre-
quencies of different ESBL/pAmpC gene groups, gene variants, and phylogroups over subse-
quent sampling stages across the whole broiler production pyramid. Statistical analysis was
performed using STATA (StataCorp, College Station, USA).
To quantify the possible transfer of ESBL/pAmpC E. coli across the broiler production pyra-
mid, the average pairwise overlap of ESBL/pAmpC genes and E. coli gene groups (M1), gene
groups plus gene variants (M2), or gene groups plus gene variants plus phylogroups (M3),
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between subsequent production stages, was estimated based on the proportional similarity
index (PSI) [28], accounting for uncertainty in measurements in a Monte Carlo simulation set-
ting. PSI values range from 0 (no similarities) to 1 (total overlap). The PSI is expressed as:
PSI ¼ ð1   0:5
X
jrj;x;y;k   rj;x;y;kþ1jÞ
where r denoted the relative frequency of ESBL/pAmpC gene group (M1), ESBL/pAmpC gene
variant (as additional strata within gene group) (M2), or E. coli phylogroup (as additional
strata within the gene variant, which in turn were strata of the respective gene group) (M3) j
(with j = 1,. . ., J; and J = 7 gene groups, J = 10 gene groups plus gene variants, and J = 7 gene
groups plus gene variants plus phylogroups), in farm x (with x = 1,. . ., X; and X = 4) of chain y
(with y = 1,. . ., Y; and Y = 3) at sampling stage (i.e. production level) k (with k = 1,. . ., K; and
K = 5). The average of the PSIs calculated over the three chains and four farms per chain gave
the overall measure of overlap between sampling stages, as follows:
1
n
Xn
i¼1
PSIi ¼
PSI1 þ PSI2 þ . . .þ PSIn
n
Uncertainty was introduced in the frequencies of M1, M2 and M3 by assuming the following
probability distribution:
r1;x;y;k; r2;x;y;k; . . . ; 1  
XJ  1
j¼1
rj;x;y;k
 !
� DirichletðX1;x;y;k;X2;x;y;k; . . . ;XJ;x;y;kÞ
Where r is defined as above, and X is the number of detections of ESBL/pAmpC gene group/
gene variant/phylogroup j in farm x of chain y at sampling stage k.
This analysis was performed in @RISK (Palisade Corp., USA) by setting 10,000 iterations
with the Latin hypercube sampling technique and a seed of 1.
Results
Prevalence of ESBL/pAmpC E. coli
In total, 820 samples (i.e. 20 samples per chain-farm-sampling stage combination) were col-
lected over 40 sampling visits. From these samples, 537 confirmed E. coli isolates from
CTX-EMB were screened for phenotypic resistance to ESCs by disk diffusion and 513 (95.5%)
thereof were positive. Overall, 60.3% (95%CI 51.3–68.1%) of samples were positive for pres-
ence of ESBL/pAmpC E. coli (Fig 1). ESBL/pAmpC E. coli were recovered at all sampling
events on farms (cloacal swabs) and slaughterhouse (carcasses). A high prevalence (92.5%,
95%CI 72.1–98.3%) was found in day-old PS chicks, which dropped to 20% (95%CI, 12.9–
29.6%) during the laying period. In fattening broilers, prevalence was higher again (69.2%,
95%CI 53.6–81.3%) at the start of the production cycle, and decreased to 54.2% (95%CI 38.9–
68.6%) in the last sampling right before slaughter (Fig 1). At the end of the production pyra-
mid, ESBL/pAmpC E. coli was isolated from 61.3% (95% CI 48.1–72.9%) of carcasses (Fig 1).
In 29.2% of carcasses (n = 43 samples) positive for presence of ESBL/pAmpC E. coli by the
qualitative method, the load was below the quantification limit (1 Log CFU/mL). In samples
with countable ESBL/pAmpC E. coli the median load was 1.66 Log CFU/1 mL rinsing water
(min 1 Log CFU/mL, max 4.2 Log CFU/mL).
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ESBL/pAmpC genes and phylogroup distribution
Out of the 513 ESC-resistant isolates, 333 (64.9%) had the ESBL and 180 (35.1%) the AmpC
phenotype. By multiplex PCR, the following ESBL gene groups were identified: blaCTX-M-
group-1 (41.9% of all resistant isolates), blaSHV (17.6%), blaCTX-M-group-9 (2.9%),
blaCTX-M-group-2 (2.5%) and blaTEM (0.2%). All isolates with an AmpC phenotype were
carrying blaCMY (25.6%), except for 18 isolates in which the following mutations were discov-
ered in the ampC gene control region: −88 (C!T), −82 (A!G), −42 (C!T), −18 (G!A), −1
(C!T) and +58 (C!T). No ESBL/pAmpC genes were found for 28 ESC-resistant E. coli.
One-hundred-eighty-three isolates with a confirmed ESBL/pAmpC gene had concurrent pres-
ence of blaTEM, which upon sequencing (n = 19 isolates) proved to be blaTEM-1b, a broad-
spectrum β-lactamase.
Sequencing of ESBL genes revealed variability in blaCTX-M-group-1, which was mainly
comprised of blaCTX-M-55 (54.2%) and blaCTX-M-1 (42.4%), whereas only one isolate (1.7%) was
found for each of blaCTX-M-15 and blaCTX-M-164 (Fig 2A). Two isolates had concurrent presence
of more than one blaCTX-M-group-1 genes and thus unassignable by Sanger sequencing. In
contrast, all blaCMY, blaSHV, blaTEM belonged to the blaCMY-2, blaSHV-12 and blaTEM-52 vari-
ants, respectively. Moreover, the blaCMY-2 variant was found in all blaCMY-carrying isolates.
Overall, the most prevalent gene variants were blaCTX-M-55 and blaCMY-2 (27% each) fol-
lowed by blaCTX-M-1 (21%) and blaSHV-12 (14%). Other gene variants were only sporadically
present. All (100%) ESBL/pAmpC E. coli in PS chicks carried blaCMY-2 (Fig 2A). The relative
frequency of this latter gene variant showed a statistically significant decreasing trend (linear
slope = -0.20, SE = 0.017, p<0.0001) over subsequent production stages, but was present
throughout the production pyramid. blaCTX-M-55 appeared in PS breeders, remained present
in fattening broilers where it peaked at the end of the production cycle (39.6%), and was the
second most prevalent gene variant in chicken carcasses (30.7%), after blaCTX-M-1 (35%). The
latter was also present in broiler, but not in breeder flocks (Fig 2A). Both blaCTX-M-1 and
Fig 1. Prevalence of ESBL/pAmpC E. coli in the broiler production pyramid. From left to right: PS chicks, PS
breeders, broiler chicks, broilers and carcasses. Bars represent corresponding 95% confidence intervals.
https://doi.org/10.1371/journal.pone.0217174.g001
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blaCTX-M-55 showed a significantly increasing trend (linear slope = 0.11, SE = 0.015, p<0.0001,
and linear slope = 0.08, SE = 0.017, p<0.0001, respectively) from breeders to carcasses. Fur-
thermore, blaSHV-12-carrying E. coli were isolated from all production stages but PS chicks,
and were predominantly isolated from fattening broiler chicks (34.6%).
The most frequent E. coli genotype was phylogroup F (34.9%) followed by A (19.7%), B1
(15.1%) and B2 (12.1%). Phylogroups C, D, and E were each found in less than 10% of isolates.
In PS chicks, phylogroup B2 predominated (94.6%), whereas in PS breeders phylogroups F, A,
and B1 were equally present (25%) (Fig 2B). In subsequent production levels, phylogroup F
was the most prevalent, but other phylogroups were present as well (Fig 2B). Significantly
increasing and decreasing trends along the production chain were respectively found for phy-
logroups F (linear slope = 0.05, SE = 0.01, p = 0.009) and B2 (linear slope = -0.15, SE = 0.01,
p<0.0001).
ESBL/pAmpC genes were found in multiple E. coli phylogroups within the same produc-
tion stage, but within the same sampling stage as well (Fig 3). However, phylogroup F-
blaCTX-M-55 was the most frequent (21.1%) isolate profile, especially in fattened broilers (37%)
and carcasses (20%). In contrast, phylogroup A- and B2-blaCMY-2 were the most frequent ones
in PS chicks (100%) and PS breeders (33.4%) (Fig 3).
Fig 2. Distribution of ESBL/pAmpC genes (A) and E. coli phylogroups (B) in the broiler production pyramid. (A) cAmpC, isolates with chromosomal
mutations in the ampC promoter/attenuator. (A) and (B) from left to right: PS chicks, PS breeders, broiler chicks, broilers and carcasses.
https://doi.org/10.1371/journal.pone.0217174.g002
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ESBL/pAmpC E. coli transfer across the production pyramid
Genotyping data were used to calculate PSIs over subsequent sampling stages at three levels of
increasing stratification (M1, M2, and M3). The average stepwise transfer of ESBL/pAmpC E.
coli over the whole production pyramid was 55.5% (95%CI 48.3–61.3%) for M1, 47.7% (95%CI
42.3–53.4%) for M2, 47.2% (95%CI 44.2–50.3%) for M3. At the top of the production pyramid,
36.4 to 50.4% (depending on the level of genotyping data stratification) of ESBL/pAmpC E. coli
found in PS breeders overlapped with (and could therefore be estimated to originate from) PS
chicks (Fig 4). The overlap between fattening chicks and fattened broilers varied from 46.5 to
49.1% (M3 to M1), whereas 51.5 to 66.9% (M3 to M1) of ESBL/pAmpC E. coli found in carcasses
were likely to originate from broilers sampled before slaughter (Fig 4). In general, the overlap of
genotyping data decreased with increasing stratification of these data due to decreased chance of
finding one-to-one matches of the same genotype between two sampling stages. Moreover, the
overlap increased with decreasing time elapsed between two sampling stages (Fig 4).
Discussion
This is the first study investigating the occurrence and potential transfer of ESBL/pAmpC E.
coli across the whole broiler production pyramid in Italy. Samples predominantly originated
Fig 3. Detected isolates by phylogroup/bla-gene combination and corresponding production stages. Size of segments on the right represent the number of
isolates with a specific combination. Size of segments on the left represent the number of isolates detected in different production stages. Ribbons connecting
left and right segments represent the number of isolates with a specific combination found on the respective production stage. Chord diagram generated with
CIRCOS [29].
https://doi.org/10.1371/journal.pone.0217174.g003
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from one Italian region, which is however among the most densely populated poultry areas in
the country and thus can be considered representative of a large fraction of Italy’s poultry pro-
duction [30]. Analysis of 820 samples from three broiler production chains resulted in the
identification of ESBL/pAmpC E. coli in all farms and batches of carcasses, with an overall
prevalence of 60.3%. Day-old PS chicks showed the highest prevalence, comparable with recent
findings from the Netherlands [31], but higher than those found in Norway [7]. All ESBL/
pAmpC E. coli found in PS chicks had the AmpC phenotype, carried blaCMY-2, and belonged
predominantly to phylogroup B2. Therefore, a prevalent E. coli blaCMY-2 lineage seems to have
been introduced through the import of day-old PS chicks. However, due to the widespread
occurrence of blaCMY-2 in poultry, other sources of entry cannot be excluded [32]. It has been
speculated that the underlying reason for high prevalence at this production level is the in ovo
use of cephalosporins in supplying (grand)parent hatcheries, which selects for ESC-resistant E.
coli in the gut of young hatchlings [8]. This is a problem for Nordic countries supplied by the
same breeding stock, as the blaCMY-2 genotype introduced at the top of the production pyra-
mid in these countries spreads clonally to the bottom, is often the only identified ESBL/
pAmpC gene [7,33,34]. Similar findings have been described in Denmark [12]. In contrast, we
found a significant decrease of blaCMY-2 and a gradual substitution by mainly blaCTX-M-55 and
blaCTX-M-1 along the production pyramid, as well as the sharp reduction of prevalence in PS
breeders (Fig 1). A similar decrease in the prevalence of blaCMY-2-carrying E. coli from 95% in
week 1 to 0% in week 21 has been described by Dame-Korevaar et al. [31] and was attributed
to a selective disadvantage of blaCMY-2-carrying plasmids. Although different EBSL/pAmpC
genotypes were identified during the laying period, blaCMY-2 was still dominant and the over-
lap of genotype distributions between the two sampling stages in breeders was substantial
Fig 4. Transfer of ESBL/pAmpC E. coli across the production pyramid. BrS1, PS chicks; BrS2, PS breeders; F1-4S1,
farm 1–4 broiler chicks; F1-4S2, farm 1–4 broilers; F1-4Sc, farm 1–4 carcasses. Arrows and text boxes indicate the
overlap of genotyping data in subsequent sampling stages (bold) at three levels (M1-M3) of increasing stratification.
Underlined text indicates the time elapsed between sampling two consecutive stages.
https://doi.org/10.1371/journal.pone.0217174.g004
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despite the relatively long period between them (36.4–50.4%). Persistence of blaCMY-2 has been
previously associated with the IncK and IncI1 plasmid types [11].
In broilers at the start of the cycle, 47.9–55.5% of the ESBL/pAmpC E. coli were likely to
have been vertically transmitted from their parents. The impact of the hatchery on colonisation
of hatchlings with ESC-resistant E. coli was not in the scope of this study. However, the role of
the hatchery has proven to be trivial since ESBLs/pAmpCs found in the hatchery’s environ-
ment (e.g. dust and incubators) were different than those recovered from the egg surface and
hatchlings [20,35]. As Projahn et al. [14] showed, true vertical transmission (infection during
egg formation) is rare and hatchlings seem to get colonised through a mode of pseudo-vertical
transmission with contaminated eggs that enter the hatchery. Nonetheless, the finding that at
least 43.3% of ESBLs/pAmpCs recovered in broiler chicks originated from their parents sup-
ports the notion of a combination of vertical transmission and environmental contamination
from the farm environment, together with rapid proliferation of resistant bacteria, resulting
into high prevalence (69.2%) and diversity of ESBL/pAmpC E. coli in young broilers [36]. The
number of positive faecal samples was 15% lower in fattened broilers, which can be explained
by the development of immunity to certain (resistant) E. coli genotypes [37]. However, high
transmission ratios and repeated shifts in phylogroups of ESBL/pAmpC E. coli during the fat-
tening period, such as the ones observed in our study (Fig 3) lead to persistence of ESC-resis-
tant E. coli in broiler flocks during the fattening period [37,38]. The overall transfer of EBSL/
pAmpC-EC from the start to the end of the broiler production cycle was, on average, 46.5–
49.1%, which indicates substantial influence of other sources, such as the environment and the
effect of previously fattened flocks, on the genotype landscape of ESBL/pAmpC E. coli [15].
This has been documented by, e.g., the finding of blaCTX-M-2 being only present in fattened
broilers, but not in fattening chicks (Fig 2A). The high levels of resistance found are difficult to
explain since no cephalosporins were administered in the investigated flocks, but the use of
amoxicillin, which was frequent in our study (S1 Fig), could have selected for ESBL/pAmpC E.
coli [7].
At the end of the production pyramid, a large proportion of carcasses (61.3%) were found
to be contaminated with ESBL/pAmpC E. coli, which is comparable with prevalence found in
previous studies [16,39,40], although the load of resistant E. coli was lower in our study. This is
a worrying finding since contamination of meat with ESBL/pAmpC E. coli is directly linked
with human exposure [21]. The contribution of chicken meat as a source of human ESBL-
pAmpC E. coli infections is debatable [19,20,41], however, the finding of phylogenetically
related strains with the same gene and plasmid profile shared between patients and poultry
meat [17,42–44] warrants for measures to prevent the entrance of ESBL/pAmpC E. coli in the
lower levels of the food chain. The highest percentage of transfer of ESBL/pAmpC E. coli
between fattened broilers and carcasses points to contamination of carcasses during processing
at the slaughterhouse [39], but the time elapsed between these two sampling stages was the
shortest (Fig 4). However, results at this production stage need to be interpreted with caution
as cross-contamination from previously slaughtered flocks via other routes (e.g. scalding
water, defeathering machines, transportation crates) is frequent [16,39,45].
Our study proved that the genetic background of ESBL/pAmpC E. coli in broilers is com-
plex in all production stages, except perhaps for PS chicks, which isolates belonged predomi-
nantly to phylogroup B2-blaCMY-2 (Figs 2 and 3). In subsequent production stages, we found
common (e.g. blaCTX-M-1, blaSHV-12) and less common (e.g. blaCTX-M-65, blaCTX-M-2) poultry-
related ESBL/AmpC genes [8] to be associated with more than one phylogroup (Fig 3), even
within the same farm (data not shown), suggesting that horizontal gene transfer contributes to
the dissemination of resistance genes, as previously discussed [13]. In contrast, persistence of
phylogroup F-blaCTX-M-55 in significant proportions of isolates from breeders to the
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slaughterhouse is indicative of clonal transmission (Fig 3). An unexpected discovery was the
occurrence of blaCTX-M-55 in all production stages except for PS chicks, especially in fattened
broilers where it was the most dominant gene (Fig 2A). This is an ESBL gene usually found in
food-producing animals and humans in Asia [46] and has been rarely described in poultry in
Europe [18,32]. Regarding E. coli genotypes, from PS chicks we observed a significant reduc-
tion of the predominant phylogroup B2, which was mainly substituted by group F in broilers
and carcasses (Fig 2B). Both phylogroups are associated with extra-intestinal pathogenicity, as
they often harbour virulence genes not found in other E. coli genotypes [47]. However, isolates
belonging to commensal groups (A, B1, and C) were substantially present as well (37% of all
isolates) (Fig 2B).
In conclusion, ESBL/pAmpC E. coli were detectable at all levels of the broiler production
pyramid. The highest prevalence was observed in imported PS chicks, with almost all samples
being positive for ESBL/pAmpC E. coli, particularly to blaCMY-2. Measures to ensure ESBL-free
pedigree flocks in supplying countries and avoid introduction of resistant clones by the pur-
chase of (grand)parent stock is therefore warranted [12,18]. Based on the similarity of ESBL/
pAmpC E. coli genotype distributions between subsequent production levels, we showed that
the transfer of ESBL/pAmpC E. coli across the whole production pyramid is likely to be sub-
stantial, with approximately half of the genotypes found in a given production stage being
likely to originate from the previous stage, and with the time between sampling stages and dis-
criminatory power of genotyping data having an effect as well. Interventions like competitive
exclusion [38] may help to control dissemination of ESBL/pAmpC E. coli. Mitigation strategies
should definitely include biosecurity and disinfection measures to avoid colonisation from
environmental sources [15,21]. Prevention of cross-contamination in the slaughterhouse pro-
cessing line is also crucial, as the load of ESBL/pAmpC E. coli on meat defines human
exposure.
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